Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Parexel Appoints EVP, Chief Quality Officer | Contract Pharma
Promotions & Moves

Parexel Appoints EVP, Chief Quality Officer

John Bell, clinical research veteran, to lead Quality initiatives across global organization

Parexel has appointed John Bell executive vice president and chief quality officer. Mr. Bell has more than 30 years of experience in clinical research with broad exposure to all major areas of clinical research quality. He will also serve on the company’s executive leadership team. He has provided global leadership for Parexel’s quality organization since 2006.
 
Mr. Bell began his career at the FARMOVS Research Centre in Bloemfontein, South Africa, which was later acquired by Parexel. He relocated to Berlin as head of Quality Management for Clinical Pharmacology before becoming vice president, Worldwide Head of Quality Management and ultimately progressing to chief quality officer and senior vice president, Corporate Quality. Mr. Bell is based in Durham, N.C.
 
“At Parexel, quality is critical to our mission and extends beyond Quality Assurance into every aspect of our organization,” said Jamie Macdonald, Chief Executive Officer. “John’s experience leading our global Quality organization as well as his history and deep understanding of our broader organization built over a long and successful tenure provides a solid background for leading quality initiatives from the highest level of the organization.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters